Why SELLAS Life Sciences Group (SLS) Stock Rose 3.06% in 10 Minutes on Nov 19, 2026
MoveSurge measured one earlier SELLAS Life Sciences Group headline with an attributed reaction between Aug 21, 2026 and Nov 18, 2026: +4.05% in 10 minutes, on Oct 28, 2026.
- SLS rose 3.06% in the 10 minutes after the 06:52:02 ET headline, from $13.72 to $14.14.
- 354,486 shares changed hands in those 10 minutes, 159.1 times the stock's normal volume for that stretch of the session.
- The headline crossed in pre-market trading, 2 hours 38 minutes before the 9:30 ET open.
06:52:02 ET
Reaction by asset (real prices)
| Asset | 2m before | At release | +1m | +10m | +1m % | +10m % |
|---|---|---|---|---|---|---|
| SLS Volume 159.1× normal in 15 min |
13.72 | 13.72 | 13.76 | 14.14 | +0.29% | +3.06% |
SELLAS Life Sciences Group (SLS) shares rose 3.06% in the 10 minutes after this headline reached the MoveSurge news feed at 06:52:02 ET on Thursday, November 19, 2026: “SELLAS Life Sciences prices a $150 million stock sale at a steep discount”
SLS in the first 10 minutes
From a reference price of $13.72 just before the headline, the stock was up 0.29% after one minute and up 3.06%, at $14.14, after 10 minutes. The first minute was nearly flat; the move came after it. 354,486 shares changed hands in those 10 minutes, 159.1 times the stock's normal volume for that stretch of the session. The headline crossed in pre-market trading, 2 hours 38 minutes before the 9:30 ET open.
Other SLS headlines on November 19, 2026
- 09:33 ET: “SELLAS Life Sciences prices a $150 million stock sale at a steep discount” (+1.01% in 10 minutes)
Earlier SLS headlines and the measured reaction
MoveSurge measured one earlier SELLAS Life Sciences Group headline with an attributed reaction between Aug 21, 2026 and Nov 18, 2026: +4.05% in 10 minutes, on Oct 28, 2026.
- Oct 28, 2026, 08:35 ET: “SELLAS Life Sciences says its Phase 3 REGAL trial of galinpepimut-S (GPS) for acute myeloid leukemia has reached its 80th event” (+4.05% in 10 minutes)
SELLAS Life Sciences Group at a glance
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Market value | $3.66 billion (as of Nov 20, 2026) |
Prices are closes of 1-minute bars. Each move on this page is measured from the last completed bar before its headline.
What headline moved SELLAS Life Sciences Group stock on November 19, 2026?
At 06:52:02 ET, this headline crossed: “SELLAS Life Sciences prices a $150 million stock sale at a steep discount”. The stock rose 3.06% in the next 10 minutes.
How far did SLS move after the headline?
From $13.72 just before the headline to $14.14 10 minutes later, a +3.06% move.
Sources
-
SLS headline and measured reaction, Nov 19, 2026
— MoveSurge
The headline as it crossed, its timestamp, and the measured price reaction reported on this page.
Follow SLS live
The live feed pairs breaking headlines with measured price moves. Build a watchlist of stocks you own and choose whether matching news reaches your WhatsApp.
Open the live feed See portfolio WhatsApp alerts